Preparation of Artificial Red Blood Cells (Hemoglobin Vesicles) Using the Rotation–Revolution Mixer for High Encapsulation Efficiency
Source abstract
Abstract
Hemoglobin vesicles (Hb-V) are artificial red blood cells encapsulating highly concentrated hemoglobin (Hb) in liposomes comprising phospholipids, cholesterol, negatively charged lipids, and polyethylene glycol (PEG)-conjugated phospholipids. Safety and efficacy of Hb-V as a transfusion alternative have been extensively studied. For this study, we prepared Hb-V using the kneading method with a rotation–revolution mixer as an alternative to the conventional extrusion method. We optimized the kneading operation parameters to obtain Hb-V with a high yield. Results show that the Hb encapsulation efficiency was increased dramatically up to 74.2%, which is higher than that of the extrusion method (20%) because the kneading method enabled mixing of a highly concentrated carbonylhemoglobin (HbCO) solution (40 g/dL) and a considerably large amount of powdered lipids in only 10 min. The high viscosity of the Hb–lipid mixture paste (ca. 103–105 cP) favorably induces frictional heat by kneading and increases the paste temperature (ca. 60 °C), which facilitates lipid dispersion and liposome formation. During the kneading operation using a thermostable HbCO solution, Hb denaturation was prevented. Hb-V prepared using this method showed no marked changes in particle sizes, Hb denaturation, or Hb leakage from liposomes during two years of long-term storage-stability tests. Collectively, these results demonstrate that the kneading method using a rotation–revolution mixer shows good potential as a new method to produce Hb-V.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Hemoglobin structure and function · Erythrocyte Function and Pathophysiology · Neonatal Health and Biochemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Japan
Funding
Japan Agency for Medical Research and Development · Ministry of Health, Labour and Welfare
References (65)
Show source-provided references
1. 10.1021/cr970143c10.1021/cr970143c ↗
2. 10.1038/nrd165910.1038/nrd1659 ↗
3. 10.1213/ANE.000000000000395710.1213/ANE.0000000000003957 ↗
4. 10.1021/bc800431d10.1021/bc800431d ↗
5. 10.1097/00003086-199812000-0001310.1097/00003086-199812000-00013 ↗
6. 10.1146/annurev.med.50.1.33710.1146/annurev.med.50.1.337 ↗
7. 10.1152/ajpheart.2000.279.3.H90810.1152/ajpheart.2000.279.3.H908 ↗
8. 10.1152/japplphysiol.00622.200910.1152/japplphysiol.00622.2009 ↗
9. 10.1006/biol.1997.009610.1006/biol.1997.0096 ↗
10. 10.1073/pnas.84.20.728010.1073/pnas.84.20.7280 ↗
11. 10.1097/TA.0b013e3181bbfaac10.1097/TA.0b013e3181bbfaac ↗
12. 10.1007/BF0188685310.1007/BF01886853 ↗
13. Iwashita Y. · Biomat. Artif. Cells Immbol. · 1992 · 20 · 299
14. 10.1111/trf.1479910.1111/trf.14799 ↗
15. 10.1016/j.freeradbiomed.2018.12.03010.1016/j.freeradbiomed.2018.12.030 ↗
16. 10.1016/j.bbapap.2009.04.00810.1016/j.bbapap.2009.04.008 ↗
17. 10.1021/bm301085x10.1021/bm301085x ↗
18. 10.1021/acs.langmuir.0c0169810.1021/acs.langmuir.0c01698 ↗
19. 10.1016/S0076-6879(09)65019-910.1016/S0076-6879(09)65019-9 ↗
20. 10.1007/978-1-4684-7908-9_1310.1007/978-1-4684-7908-9_13 ↗
21. 10.1021/bp950068w10.1021/bp950068w ↗
22. 10.1021/bm050145410.1021/bm0501454 ↗
23. 10.1021/la903634310.1021/la9036343 ↗
24. 10.1016/S0022-2836(64)80115-710.1016/S0022-2836(64)80115-7 ↗
25. 10.1126/science.146.3643.52410.1126/science.146.3643.524 ↗
26. 10.1021/la940936j10.1021/la940936j ↗
27. 10.1021/bp020100410.1021/bp0201004 ↗
28. 10.1021/bc960069p10.1021/bc960069p ↗
29. 10.1124/jpet.104.07453410.1124/jpet.104.074534 ↗
30. 10.1080/08982104.2019.166801010.1080/08982104.2019.1668010 ↗
31. 10.1186/1556-276X-8-10210.1186/1556-276X-8-102 ↗
32. 10.1016/j.chemphyslip.2013.10.01110.1016/j.chemphyslip.2013.10.011 ↗
33. Phillips W. T. · J. Pharmacol. Exp. Ther. · 1999 · 288 · 665
34. 10.1021/acs.langmuir.6b0464310.1021/acs.langmuir.6b04643 ↗
35. 10.1016/j.cherd.2015.05.04510.1016/j.cherd.2015.05.045 ↗
36. 10.1007/s00348-021-03146-210.1007/s00348-021-03146-2 ↗
37. Massing U. · 2017
38. 10.1016/j.ijpharm.2007.08.02710.1016/j.ijpharm.2007.08.027 ↗
39. 10.1080/0022234050032365610.1080/00222340500323656 ↗
40. 10.1023/A:101604420416810.1023/A:1016044204168 ↗
41. 10.1111/j.2042-7158.1995.tb05811.x10.1111/j.2042-7158.1995.tb05811.x ↗
42. 10.1016/j.jconrel.2007.09.01010.1016/j.jconrel.2007.09.010 ↗
43. 10.1016/j.jconrel.2008.11.02910.1016/j.jconrel.2008.11.029 ↗
44. 10.1016/j.ejps.2017.07.01310.1016/j.ejps.2017.07.013 ↗
45. 10.3109/03639045.2015.113594010.3109/03639045.2015.1135940 ↗
46. 10.1093/oxfordjournals.jbchem.a00314110.1093/oxfordjournals.jbchem.a003141 ↗
47. 10.1007/s11095-011-0457-y10.1007/s11095-011-0457-y ↗
48. 10.1016/j.ijpharm.2020.11908710.1016/j.ijpharm.2020.119087 ↗
49. 10.1021/la700450310.1021/la7004503 ↗
50. 10.1016/0005-2736(68)90132-610.1016/0005-2736(68)90132-6 ↗
51. 10.1016/j.bbamem.2008.01.00610.1016/j.bbamem.2008.01.006 ↗
52. 10.1002/jbm.a.3420810.1002/jbm.a.34208 ↗
53. 10.1021/bc990173h10.1021/bc990173h ↗
54. 10.1021/bc990135y10.1021/bc990135y ↗
55. 10.1111/j.1742-4658.2007.05685.x10.1111/j.1742-4658.2007.05685.x ↗
56. Kandler, R. L.; Spicussa, J. C. Stable Hemoglobin Based Composition and Method to Store Same. WO1992002239A1, 20-02-1992
57. 10.1016/S0021-9258(18)90579-X10.1016/S0021-9258(18)90579-X ↗
58. 10.1021/bc00029a00110.1021/bc00029a001 ↗
59. 10.1021/bi001420410.1021/bi0014204 ↗
60. 10.1021/bp010123310.1021/bp0101233 ↗
61. 10.3390/jfb801001010.3390/jfb8010010 ↗
62. 10.1016/j.ajog.2020.09.01010.1016/j.ajog.2020.09.010 ↗
63. 10.1371/journal.pone.022618310.1371/journal.pone.0226183 ↗
64. 10.1016/j.jconrel.2016.05.01610.1016/j.jconrel.2016.05.016 ↗
65. 10.1097/PRS.000000000000308210.1097/PRS.0000000000003082 ↗